Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Jul;73(7-8):370-375.

[Acute respiratory distress revealing antisynthetase syndrome]

[Article in French]
Affiliations
  • PMID: 30113776
Free article
Case Reports

[Acute respiratory distress revealing antisynthetase syndrome]

[Article in French]
Q Maloir et al. Rev Med Liege. 2018 Jul.
Free article

Abstract

Antisynthetase syndrome is a clinical entity characterized by specific anti-aminoacyl-tRNA-synthetase antibodies usually associated with inflammatory myopathy and interstitial lung disease. The classic presentation of the pathology is the pulmonary interstitium involvment, wich commonly determines the global prognosis. The subsequent diagnosis of antisynthetase syndrome in patients with acute respiratory distress syndrome (ARDS) is unusual, even more so when a veino-veinous (VV) extracorporeal membrane oxygenation (ECMO) is required. This article presents a clinical case of antisynthetase syndrome with severe ARDS successfully treated with immunosuppressive agents and ECMO.

Le syndrome des antisynthétases (SAS) est une pathologie multi-systémique auto-immune rare caractérisée par un trépied diagnostique associant la présence d’auto-anticorps anti-aminoacyl-ARNt synthétase, une myopathie inflammatoire et une pneumopathie interstitielle diffuse. L’atteinte pulmonaire parenchymateuse est la plus fréquemment rencontrée et détermine, de manière presque systématique, le pronostic global de la pathologie. L’identification d’un syndrome des antisynthétases dans le décours d’un syndrome de détresse respiratoire aigüe (SDRA) est rare, d’autant plus lorsque la mise en place d’un système d’oxygénation par membrane extracorporelle (ECMO) veino-veineuse (VV) est requise. Cet article présente un cas de SAS avec SDRA sévère, traité avec succès par immunosuppresseurs et ECMO.

Keywords: ARDS; ECMO; Interstitial lung disease; JO1; Myositis; Antisynthetase.

PubMed Disclaimer

Publication types

Supplementary concepts